General MedicationsORALGeneric
OXYTETRACYCLINE HYDROCHLORIDE
OXYTETRACYCLINE HYDROCHLORIDE
Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview OXYTETRACYCLINE HYDROCHLORIDE is listed in Drugs@FDA under application 060869 (ANDA).
Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor PROTER Submission history Latest submission status date: 1964-01-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview OXYTETRACYCLINE HYDROCHLORIDE is listed in Drugs@FDA under application 060869 (ANDA). Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor PROTER Submission history Latest submission status date: 1964-01-29 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.